Cancer is one of the most deadly diseases and is estimated to affect one in three people, especially in the western world. WHO (World Health Organisation) claims that there has been a 70% increase in the number of cancer cases across the world with the number continuously on the rise each year. In addition to being deadly, cancer treatment costs a bomb, at least for the common people.
New improvements in cancer treatment
The cellular and micro-environmental processes in chronic fibrosis and cancer are identical. Swiss clinical stage biotechnology company iOnctura is building on this link to develop a pipeline of next generation, differentiated molecules that are at the forefront of pioneering new therapies for the treatment of cancer.